| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Bredt David is a Chief Scientific Officer at RAPP. Recent filings cover 0 purchases and 18 sales. Those positions are worth an estimated $19.4M at current prices.
Our model assigns Bredt David a below-average insider score of 24/100, based on 12 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -100.0%.
Bredt David's largest disclosed position is in RAPP as Chief Scientific Officer, worth about $19.4M. The recent filings there lean toward selling, a net 100,067 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15, 2025 | RAPP Rapport Therapeutics, Inc. | Chief Scientific Officer | Sell | 8,500 | $9.57 | $81,310.15 | -1.8% | +52.4% | +255.9% | |
| Mar 14, 2025 | RAPP Rapport Therapeutics, Inc. | Chief Scientific Officer | Sell | 8,500 | $10.85 | $92,205.45 | -1.8% | +6.0% | +164.9% |